277 related articles for article (PubMed ID: 26861273)
21. The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease.
Hepnarova V; Korabecny J; Matouskova L; Jost P; Muckova L; Hrabinova M; Vykoukalova N; Kerhartova M; Kucera T; Dolezal R; Nepovimova E; Spilovska K; Mezeiova E; Pham NL; Jun D; Staud F; Kaping D; Kuca K; Soukup O
Eur J Med Chem; 2018 Apr; 150():292-306. PubMed ID: 29533874
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
[TBL] [Abstract][Full Text] [Related]
23. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.
Muñoz-Ruiz P; Rubio L; García-Palomero E; Dorronsoro I; del Monte-Millán M; Valenzuela R; Usán P; de Austria C; Bartolini M; Andrisano V; Bidon-Chanal A; Orozco M; Luque FJ; Medina M; Martínez A
J Med Chem; 2005 Nov; 48(23):7223-33. PubMed ID: 16279781
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity.
Li JC; Zhang J; Rodrigues MC; Ding DJ; Longo JP; Azevedo RB; Muehlmann LA; Jiang CS
Bioorg Med Chem Lett; 2016 Aug; 26(16):3881-5. PubMed ID: 27426301
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of human acetylcholinesterase by xanthine derivatives: in vitro inhibition and molecular modeling investigations.
Mohamed T; Osman W; Tin G; Rao PP
Bioorg Med Chem Lett; 2013 Aug; 23(15):4336-41. PubMed ID: 23791077
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
Sang Z; Pan W; Wang K; Ma Q; Yu L; Liu W
Bioorg Med Chem; 2017 Jun; 25(12):3006-3017. PubMed ID: 28487125
[TBL] [Abstract][Full Text] [Related]
30. Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study.
Ghosh S; Jana K; Ganguly B
Phys Chem Chem Phys; 2019 Jul; 21(25):13578-13589. PubMed ID: 31173012
[TBL] [Abstract][Full Text] [Related]
31. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Son M; Park C; Rampogu S; Zeb A; Lee KW
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
[TBL] [Abstract][Full Text] [Related]
32. Tacrine-coumarin and Tacrine-7-chloroquinoline Hybrids with Thiourea Linkers: Cholinesterase Inhibition Properties, Kinetic Study, Molecular Docking and Permeability Assay for Blood-brain Barrier.
Hamulakova S; Janovec L; Soukup O; Jun D; Janockova J; Hrabinova M; Sepsova V; Kuca K
Curr Alzheimer Res; 2018; 15(12):1096-1105. PubMed ID: 29992880
[TBL] [Abstract][Full Text] [Related]
33. Pyridonepezils, new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease: synthesis, biological assessment, and molecular modeling.
Samadi A; Estrada M; Pérez C; Rodríguez-Franco MI; Iriepa I; Moraleda I; Chioua M; Marco-Contelles J
Eur J Med Chem; 2012 Nov; 57():296-301. PubMed ID: 23078965
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy.
Kou X; Song L; Wang Y; Yu Q; Ju H; Yang A; Shen R
Bioorg Med Chem Lett; 2020 Feb; 30(4):126927. PubMed ID: 31901382
[TBL] [Abstract][Full Text] [Related]
35. A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease.
Patel A; Shah D; Patel Y; Patel S; Mehta M; Bambharoliya T
Curr Drug Targets; 2023; 24(3):225-246. PubMed ID: 36515018
[TBL] [Abstract][Full Text] [Related]
36. Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease.
Xie SS; Wang X; Jiang N; Yu W; Wang KD; Lan JS; Li ZR; Kong LY
Eur J Med Chem; 2015 May; 95():153-65. PubMed ID: 25812965
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular docking of new acridine-coumarin hybrids.
Hamulakova S; Janovec L; Soukup O; Jun D; Kuca K
Int J Biol Macromol; 2017 Nov; 104(Pt A):333-338. PubMed ID: 28601645
[TBL] [Abstract][Full Text] [Related]
38. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease.
Meena P; Nemaysh V; Khatri M; Manral A; Luthra PM; Tiwari M
Bioorg Med Chem; 2015 Mar; 23(5):1135-48. PubMed ID: 25624107
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase.
Catto M; Pisani L; Leonetti F; Nicolotti O; Pesce P; Stefanachi A; Cellamare S; Carotti A
Bioorg Med Chem; 2013 Jan; 21(1):146-52. PubMed ID: 23199476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
